4,688 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Bought by Portside Wealth Group LLC

Portside Wealth Group LLC bought a new position in Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 4,688 shares of the company’s stock, valued at approximately $287,000.

Other hedge funds also recently bought and sold shares of the company. Trexquant Investment LP boosted its holdings in shares of Prestige Consumer Healthcare by 109.1% during the 3rd quarter. Trexquant Investment LP now owns 8,340 shares of the company’s stock valued at $477,000 after purchasing an additional 4,351 shares during the last quarter. Qube Research & Technologies Ltd boosted its holdings in shares of Prestige Consumer Healthcare by 91.4% during the 3rd quarter. Qube Research & Technologies Ltd now owns 72,092 shares of the company’s stock valued at $4,123,000 after purchasing an additional 34,430 shares during the last quarter. SG Americas Securities LLC bought a new position in shares of Prestige Consumer Healthcare during the 3rd quarter valued at about $1,632,000. Connors Investor Services Inc. bought a new position in shares of Prestige Consumer Healthcare in the 3rd quarter valued at about $1,569,000. Finally, Hsbc Holdings PLC lifted its holdings in shares of Prestige Consumer Healthcare by 17.1% in the 3rd quarter. Hsbc Holdings PLC now owns 22,075 shares of the company’s stock valued at $1,263,000 after acquiring an additional 3,226 shares during the last quarter. Institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on PBH shares. TheStreet raised shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. One equities research analyst has rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus price target of $110.00.

Get Our Latest Stock Report on PBH

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 5,336 shares of the stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $69.00, for a total value of $368,184.00. Following the sale, the senior vice president now directly owns 15,934 shares of the company’s stock, valued at approximately $1,099,446. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Prestige Consumer Healthcare Trading Up 0.7 %

Shares of NYSE:PBH opened at $72.06 on Wednesday. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75. Prestige Consumer Healthcare Inc. has a 12 month low of $55.96 and a 12 month high of $75.31. The company has a 50-day moving average price of $68.09 and a 200 day moving average price of $62.38.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last posted its quarterly earnings data on Thursday, February 8th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.02. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The company had revenue of $282.74 million for the quarter, compared to analyst estimates of $280.25 million. During the same period in the prior year, the company posted $1.04 EPS. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. As a group, research analysts expect that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current fiscal year.

About Prestige Consumer Healthcare

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

See Also

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.